Clinical Trial Update: A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update describing a study of long-acting antibodies, alone and in combinations, for moderate to severe ulcerative colitis; currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Long-acting antibodies (investigational)

Snippet

Sponsor: Spyre Therapeutics, Inc. | Conditions: Ulcerative Colitis, Inflammatory Bowel Diseases | Phase 2 | Status: RECRUITING